InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Emyria Limited (ASX: EMD) - Announcements

- Current share price for EMD : $0.045

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$36 Notice under section 708A(5)(e) of the Corporations Act 1 Dec 2021 6:31PM $0.495 $0.045 fallen by 90.91%
$36 Application for quotation of securities - EMD 1 Dec 2021 6:26PM $0.495 $0.045 fallen by 90.91%
$36 Application for quotation of securities - EMD 1 Dec 2021 6:18PM $0.495 $0.045 fallen by 90.91%
$36 Initial Director's Interest Notice KS 30 Nov 2021 8:26PM $0.460 $0.045 fallen by 90.22%
$36 Emyria Appoints Global Pharma Expert Dr Karen Smith to Board 29 Nov 2021 10:09AM $0.440 $0.045 fallen by 89.77%
$36 Emyria Anoints Global Pharma Expert Dr Karen Smith to Board 29 Nov 2021 9:47AM $0.440 $0.045 fallen by 89.77%
$36 Change in substantial holding SW 26 Nov 2021 6:57PM $0.440 $0.045 fallen by 89.77%
$36 Change in substantial holding MW 26 Nov 2021 6:54PM $0.440 $0.045 fallen by 89.77%
$36 Change in substantial holding MT 26 Nov 2021 6:53PM $0.440 $0.045 fallen by 89.77%
$36 Change in substantial holding CD 26 Nov 2021 6:53PM $0.440 $0.045 fallen by 89.77%
$36 Becoming a substantial holder TAT 25 Nov 2021 8:32AM $0.435 $0.045 fallen by 89.66%
$36 Notification regarding unquoted securities - EMD 24 Nov 2021 6:02PM $0.435 $0.045 fallen by 89.66%
$36 Application for quotation of securities - EMD 24 Nov 2021 5:59PM $0.435 $0.045 fallen by 89.66%
$36 Notice under section 708A(5)(e) of the Corporations Act 24 Nov 2021 5:54PM $0.435 $0.045 fallen by 89.66%
$36 Emyria receives $1,162,000 R&D Tax Incentive Refund 24 Nov 2021 9:39AM $0.425 $0.045 fallen by 89.41%
$36 Application for quotation of securities - EMD 22 Nov 2021 7:03PM $0.390 $0.045 fallen by 88.46%
$36 Proposed issue of securities - EMD 22 Nov 2021 9:50AM $0.325 $0.045 fallen by 86.15%
$36 Emyria Welcomes Tattarang as Strategic Investor 22 Nov 2021 9:50AM $0.325 $0.045 fallen by 86.15%
$36 Trading Halt 19 Nov 2021 9:34AM $0.325 $0.045 fallen by 86.15%
$36 Results of Meeting 3 Nov 2021 3:47PM $0.295 $0.045 fallen by 84.75%
$36 Notification regarding unquoted securities - EMD 1 Nov 2021 6:37PM $0.250 $0.045 fallen by 82%
$36 Appendix 4C - Quarterly 26 Oct 2021 10:15AM $0.240 $0.045 fallen by 81.25%
$36 MDMA Analogue Development Milestone 19 Oct 2021 9:42AM $0.225 $0.045 fallen by 80%
$36 Notification of cessation of securities - EMD 18 Oct 2021 5:57PM $0.225 $0.045 fallen by 80%
$36 Notification of cessation of securities - EMD 18 Oct 2021 5:54PM $0.225 $0.045 fallen by 80%

376 - 400 of 553 results

Page 16 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.